Bloomage BioTechnology Corporation Limited (688363.SS) SHH

47.55

-0.22(-0.46%)

Updated at April 18 03:00PM

Currency In CNY

Bloomage BioTechnology Corporation Limited

Address

Tech Development Zone

Jinan, 250101

China

Phone

86 531 8268 5998

Sector

Basic Materials

Industry

Chemicals - Specialty

Employees

4655

First IPO Date

November 12, 2019

Key Executives

NameTitlePayYear Born
Mr. Jiajun GuoDeputy GM & Director01975
Ms. Yuan FanDirector & Vice President of Business01983
Mr. Songyan ZouDirector & Vice President of Business01982
Mr. Yizheng LiDeputy GM, Secretary of the Board of Directors & Director01984
Ms. Gao YiDeputy General Manager01973
Mr. Hui WangChief Accountant, Deputy GM, Chief Financial Officer & Financial Director01983
Ms. Yan ZhaoChairman & GM01966
Mr. Xueping GuoDeputy GM of Core Technician & Director01965

Description

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China.